ATE267018T1 - Verwendung von peptidverbindungen zur behandlung von sle - Google Patents

Verwendung von peptidverbindungen zur behandlung von sle

Info

Publication number
ATE267018T1
ATE267018T1 AT98830310T AT98830310T ATE267018T1 AT E267018 T1 ATE267018 T1 AT E267018T1 AT 98830310 T AT98830310 T AT 98830310T AT 98830310 T AT98830310 T AT 98830310T AT E267018 T1 ATE267018 T1 AT E267018T1
Authority
AT
Austria
Prior art keywords
peptide compounds
treat sle
sle
treat
thr
Prior art date
Application number
AT98830310T
Other languages
English (en)
Inventor
Maria Marino
Maria Rossi
Giorgio Fassina
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Application granted granted Critical
Publication of ATE267018T1 publication Critical patent/ATE267018T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98830310T 1998-05-21 1998-05-21 Verwendung von peptidverbindungen zur behandlung von sle ATE267018T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98830310A EP0958829B1 (de) 1998-05-21 1998-05-21 Verwendung von Peptidverbindungen zur Behandlung von SLE

Publications (1)

Publication Number Publication Date
ATE267018T1 true ATE267018T1 (de) 2004-06-15

Family

ID=8236657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98830310T ATE267018T1 (de) 1998-05-21 1998-05-21 Verwendung von peptidverbindungen zur behandlung von sle

Country Status (7)

Country Link
US (1) US6303577B1 (de)
EP (1) EP0958829B1 (de)
JP (1) JP2000053580A (de)
AT (1) ATE267018T1 (de)
CA (1) CA2270687A1 (de)
DE (1) DE69823981T2 (de)
ES (1) ES2218796T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1042114B (zh) 1998-10-23 2006-09-29 Amgen K-A, Inc. 与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
US7442778B2 (en) 2004-09-24 2008-10-28 Amgen Inc. Modified Fc molecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
EP3134732A2 (de) * 2014-04-24 2017-03-01 Alnylam Pharmaceuticals, Inc. Verfahren und zusammensetzungen zum nachweis von anti-wirkstoff-antikörpern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7525796A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins

Also Published As

Publication number Publication date
EP0958829A1 (de) 1999-11-24
EP0958829B1 (de) 2004-05-19
DE69823981T2 (de) 2005-05-25
JP2000053580A (ja) 2000-02-22
ES2218796T3 (es) 2004-11-16
DE69823981D1 (de) 2004-06-24
US6303577B1 (en) 2001-10-16
CA2270687A1 (en) 1999-11-21

Similar Documents

Publication Publication Date Title
DK0842934T3 (da) 5-HT1F agonister
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
BR9814361A (pt) Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
ATE162531T1 (de) Imidazolidin-derivate
DK15589A (da) Kemiske forbindelser
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
NO944406D0 (no) Nye 7 se inhibitorer
DE69911935D1 (de) Granulatimide-derivate zur behandlung von krebs
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
DE69823981D1 (de) Verwendung von Peptidverbindungen zur Behandlung von SLE
TR199901386T2 (en) �midazopiridazinler.
IL135634A0 (en) 5-htif agonists
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE69307674D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
DE69940971D1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
ATE213413T1 (de) Verwendung von 3-(4-hexyloxy-1,2,5-thiadiazol-3- yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) zur behandlung von bipolaren störungen
DE50003481D1 (de) Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie
DE69808607D1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
ES2053808T3 (es) Nuevos compuestos azolicos.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0958829

Country of ref document: EP

REN Ceased due to non-payment of the annual fee